Genprex (GNPX) Assets (2016 - 2026)
Genprex (GNPX) posted quarterly Assets of $20.3 million for Q1 2026, up 237.89% year-over-year from $6.0 million in Q1 2025, and up 99.88% quarter-over-quarter from $10.2 million in Q4 2025.
Genprex (GNPX) Assets (2016 - 2026) Analysis & Trends
Genprex's Assets history runs 11 years deep, the most recent figure standing at $20.3 million for Q1 2026.
- In Q1 2026, Assets rose 237.89% year-over-year to $20.3 million; the TTM figure through Mar 2026 stood at $20.3 million (up 237.89% YoY), while the FY2025 annual figure was $10.2 million, up 146.32% from the prior year.
- Assets for Q1 2026 stood at $20.3 million, up from $10.2 million in the prior quarter.
- The five-year high for Assets was $39.4 million in Q1 2022, with the low at $3.6 million in Q3 2025.
- The 5-year median for Assets is $12.6 million (2024), against an average of $15.7 million.
- The sharpest annual moves came in 2024 and 2026: Assets sank 76.52% in 2024, then surged 237.89% in 2026.
- Genprex's Assets stood at $25.1 million in 2022, then slumped by 57.46% to $10.7 million in 2023, then tumbled by 61.35% to $4.1 million in 2024, then jumped by 146.32% to $10.2 million in 2025, then soared by 99.88% to $20.3 million in 2026.
- Business Quant data shows GNPX's Assets at $20.3 million in Q1 2026, $10.2 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Genprex | 2.00 Mn | -13.15 Mn | - | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.31 Mn |
| Dec 31, 2025 | 10.16 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 12.56 Mn |
| Dec 31, 2023 | 10.67 Mn |
| Sep 30, 2023 | 16.64 Mn |
| Jun 30, 2023 | 15.91 Mn |
| Mar 31, 2023 | 23.32 Mn |
| Dec 31, 2022 | 25.09 Mn |
| Sep 30, 2022 | 29.95 Mn |
| Jun 30, 2022 | 34.57 Mn |
| Mar 31, 2022 | 39.41 Mn |
| Dec 31, 2021 | 42.86 Mn |
| Sep 30, 2021 | 46.33 Mn |
| Jun 30, 2021 | 48.73 Mn |